TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
FBRX

Forte Biosciences Inc

Healthcare · Biotechnology

77.00$ +0.0% vs. previous close Closing price · As of: Aug 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement FBRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -3.9% -16.3% +43,890.2% -99.8% -100.0% – – – – –
– – – – – +390.9% -33.3% – – +333.3% +64.1%
– -3.9% -16.3% +43,890.2% -100.1% – – – – – –
– +42.0% +7.0% +73.3% -94.7% +272.2% +39.2% -59.6% +290.8% -3.1% +174.8%
– +18.0% +89.2% -96.9% +419.5% +205.8% +80.8% +8.8% +28.0% +45.0% -19.5%
– +38.3% +18.7% +69.3% -93.6% +249.6% +51.6% -35.3% +133.7% +12.6% +93.2%
– – – – – – – – – – –
– +1,701.0% +5.2% -91.0% +2,103.3% -100.0% – -92.3% – – –
– – – – – – – – – – –
– – – – -100.1% – -100.6% – – – –
– – – – – – – – – – –
– – – – – – – – – – –

Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?